Figma’s Post-IPO Volatility Tests VC Exit Sentiment as DaVita Offers Value Hedge
Figma (FIG) faces a critical public market test as it balances an OpenAI-driven product pivot against insider selling and 'moat' skepticism. Meanwhile, DaVita (DVA) remains a benchmark for defensive value, highlighting the ongoing tension between high-growth SaaS and stable healthcare assets in institutional portfolios.